Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    X4 Pharmaceuticals Inc.

    NASDAQ: XFOR · Real-Time Price · USD
    2.70
    -0.12 (-4.26%)
    At close: Jun 16, 2025, 3:59 PM
    2.79
    3.33%
    Pre-market: Jun 17, 2025, 04:05 AM EDT

    X4 Pharmaceuticals Statistics

    Share Statistics

    X4 Pharmaceuticals has 5.79M shares outstanding. The number of shares has increased by 0.49% in one year.

    Shares Outstanding

    n/a
    		 5.79M

    Shares Change (YoY)

    n/a
    		 0.49%

    Shares Change (QoQ)

    n/a
    		 0.82%

    Owned by Institutions (%)

    n/a
    		 49.7%

    Shares Floating

    n/a
    		 3.85M

    Failed to Deliver (FTD) Shares

    n/a
    		 318

    FTD / Avg. Volume

    n/a
    		 0.18%

    Short Selling Information

    The latest short interest is 396.89K, so 6.86% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 396.89K

    Short % of Shares Out

    n/a
    		 6.86%

    Short % of Float

    n/a
    		 6.95%

    Short Ratio (days to cover)

    n/a
    		 2.14

    Valuation Ratios

    The PE ratio is -118.17 and the forward PE ratio is -0.33. X4 Pharmaceuticals's PEG ratio is 1.75.

    PE Ratio

    n/a
    		 -118.17

    Forward PE

    n/a
    		 -0.33

    PS Ratio

    n/a
    		 1730.67

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 199.8

    P/FCF Ratio

    n/a
    		 -33.72

    PEG Ratio

    n/a
    		 1.75
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for X4 Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.41, with a Debt / Equity ratio of 3.53.

    Current Ratio

    n/a
    		 3.41

    Quick Ratio

    n/a
    		 3.33

    Debt / Equity

    n/a
    		 3.53

    Debt / EBITDA

    n/a
    		 -2.83

    Debt / FCF

    n/a
    		 -0.6

    Interest Coverage

    n/a
    		 -4.15

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $17,881.12

    Profits Per Employee

    n/a
    		 $-261,888.11

    Employee Count

    n/a
    		 143

    Asset Turnover

    n/a
    		 0.02

    Inventory Turnover

    n/a
    		 0.28

    Taxes

    Income Tax

    n/a
    		 310K

    Effective Tax Rate

    n/a
    		 -0.83%

    Stock Price Statistics

    The stock price has increased by -90.93% in the last 52 weeks. The beta is 0.66, so X4 Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.66

    52-Week Price Change

    n/a
    		 -90.93%

    50-Day Moving Average

    n/a
    		 4.26

    200-Day Moving Average

    n/a
    		 12.75

    Relative Strength Index (RSI)

    n/a
    		 35.1

    Average Volume (20 Days)

    n/a
    		 176,349

    Income Statement

    In the last 12 months, X4 Pharmaceuticals had revenue of 2.56M and earned -37.45M in profits. Earnings per share was -0.19.

    Revenue

    n/a
    		 2.56M

    Gross Profit

    n/a
    		 1.76M

    Operating Income

    n/a
    		 -36.4M

    Net Income

    n/a
    		 -37.45M

    EBITDA

    n/a
    		 -27.58M

    EBIT

    n/a
    		 -28.37M

    Earnings Per Share (EPS)

    n/a
    		 -0.19
    Full Income Statement

    Balance Sheet

    The company has 55.7M in cash and 78.09M in debt, giving a net cash position of -22.39M.

    Cash & Cash Equivalents

    n/a
    		 55.7M

    Total Debt

    n/a
    		 78.09M

    Net Cash

    n/a
    		 -22.39M

    Retained Earnings

    n/a
    		 -515.36M

    Total Assets

    n/a
    		 130.01M

    Working Capital

    n/a
    		 69.81M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -130.9M and capital expenditures -326K, giving a free cash flow of -131.23M.

    Operating Cash Flow

    n/a
    		 -130.9M

    Capital Expenditures

    n/a
    		 -326K

    Free Cash Flow

    n/a
    		 -131.23M

    FCF Per Share

    n/a
    		 -0.65
    Full Cash Flow Statement

    Margins

    Gross margin is 68.83%, with operating and profit margins of -1423.58% and -1464.61%.

    Gross Margin

    n/a
    		 68.83%

    Operating Margin

    n/a
    		 -1423.58%

    Pretax Margin

    n/a
    		 -1452.48%

    Profit Margin

    n/a
    		 -1464.61%

    EBITDA Margin

    n/a
    		 -1078.45%

    EBIT Margin

    n/a
    		 -1423.58%

    FCF Margin

    n/a
    		 -5132.07%

    Dividends & Yields

    XFOR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for XFOR is $90, which is 3233.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $90

    Price Target Difference

    n/a
    		 3233.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 28, 2025. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Apr 28, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -1.6

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist